1. Home
  2. TALO vs LMAT Comparison

TALO vs LMAT Comparison

Compare TALO & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Talos Energy Inc.

TALO

Talos Energy Inc.

HOLD

Current Price

$16.58

Market Cap

2.7B

Sector

Energy

ML Signal

HOLD

Logo LeMaitre Vascular Inc.

LMAT

LeMaitre Vascular Inc.

HOLD

Current Price

$101.01

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TALO
LMAT
Founded
2011
1983
Country
United States
United States
Employees
700
N/A
Industry
Oil & Gas Production
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.6B
IPO Year
2017
2006

Fundamental Metrics

Financial Performance
Metric
TALO
LMAT
Price
$16.58
$101.01
Analyst Decision
Buy
Buy
Analyst Count
5
5
Target Price
$18.00
$105.80
AVG Volume (30 Days)
1.5M
210.9K
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
0.93%
EPS Growth
N/A
30.57
EPS
N/A
0.68
Revenue
$1,780,070,000.00
$249,602,000.00
Revenue This Year
$4.18
$14.21
Revenue Next Year
N/A
$8.88
P/E Ratio
N/A
$148.23
Revenue Growth
N/A
13.53
52 Week Low
$7.67
$78.35
52 Week High
$17.01
$118.01

Technical Indicators

Market Signals
Indicator
TALO
LMAT
Relative Strength Index (RSI) 62.75 39.65
Support Level $10.49 $82.65
Resistance Level $17.01 $114.98
Average True Range (ATR) 0.55 5.12
MACD 0.09 -1.08
Stochastic Oscillator 98.45 26.42

Price Performance

Historical Comparison
TALO
LMAT

About TALO Talos Energy Inc.

Talos Energy Inc is an independent oil and gas company predominantly involved in offshore exploration and production. The company has operations in the United States, the Gulf of Mexico, and offshore Mexico. The company's operating segments are; exploration and production of oil, natural gas and NGLs, and the CCS segment. Its revenue is generated from the sale of oil, natural gas, and NGL quantities sold to purchasers.

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.

Share on Social Networks: